Previous close | 24.46 |
Open | 24.63 |
Bid | 23.00 x 1000 |
Ask | 23.49 x 900 |
Day's range | 23.21 - 24.95 |
52-week range | 16.96 - 79.88 |
Volume | |
Avg. volume | 532,243 |
Market cap | 601.075M |
Beta (5Y monthly) | 1.04 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.83 |
Earnings date | 26 Feb 2024 - 01 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 46.14 |
NEW YORK, November 10, 2023--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in two upcoming investment conferences.
Key Insights Using the 2 Stage Free Cash Flow to Equity, Establishment Labs Holdings fair value estimate is US$27.03...
NEW YORK, November 09, 2023--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has received National Medical Products Administration (NMPA) approval in China for Motiva® Implants.